echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > ACR 2021: What will happen to patients with rheumatoid arthritis "bumping" on ANCA positive and vasculitis?

    ACR 2021: What will happen to patients with rheumatoid arthritis "bumping" on ANCA positive and vasculitis?

    • Last Update: 2021-12-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background / Objective: Anti-neutrophil cytoplasmic antibody (ANCA-) correlation vascular inflammation (AAV) and rheumatoid arthritis rarely (RA) reported


    Background/Objective: Vascular Rheumatoid Arthritis

    Methods: In this retrospective study, a cohort of RA+ANCA positive patients evaluated at an academic center was included


    Method: Diagnose

    Results: The study included 77 patients with a mean (±SD) age of 60.


    result:

    25 patients (32%) were diagnosed with AAV; 9 (36%) microscopic polyangiitis (MPA), 8 (32%) granuloma with polyangiitis (GPA), 1 (4%) eosinophilic granuloma With polyangiitis (EGPA), 1 (4%) GPA and rheumatoid vasculitis (peripheral ulcerative keratitis, scleritis, sudden hearing loss, MPO positive)


    The diagnosis of RA precedes vasculitis in 92% of cases, occurs simultaneously in 4% of cases, and occurs after vasculitis in 4% of cases


    The comparison between RA+AAV patients and RA+ANCA patients without AAV is shown in Table 2


    immunity

    Conclusion: The AAV in RA includes several cases of eosinophilic granuloma with polyangiitis and microscopic polyangiitis


    Conclusion: The diagnosis of RA almost always precedes the diagnosis of AAV.


    O'Brien C, Ranganath V, Kermani T.


    Arthritis Rheumatol.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.